What is the price-to-earnings ratio of Medcom Tech?
The price-earnings ratio of Medcom Tech is currently 0.48.
Medcom Tech P/S 2024
Medcom Tech P/S
0.48
Ticker
MED.MC
ISIN
ES0161857018
As of Nov 18, 2024, Medcom Tech's P/S ratio stood at 0.48, a -29.41% change from the 0.68 P/S ratio recorded in the previous year.
The Medcom Tech P/S history
Medcom Tech Aktienanalyse
What does Medcom Tech do?
Medcom Tech SA is a European company headquartered in Switzerland that specializes in the development and manufacturing of medical devices. The company was founded in 1999 and has since had an impressive history. The business model of Medcom Tech SA is based on the idea of developing medical devices that meet the needs of doctors and patients. The company works closely with medical professionals to find innovative solutions that can improve medical care and accelerate patient recovery. The goal of Medcom Tech SA is to offer high-quality, safe, and reliable products that can be used worldwide in medical practice. Medcom Tech SA offers a wide range of products divided into various sectors. One of the main sectors of the company is gastroenterology, where endoscopic devices and accessories are manufactured and distributed. These devices are a crucial foundation for the diagnosis and treatment of gastrointestinal diseases. The endoscopes enable more precise interventions and are particularly in demand for minimally invasive procedures. Another important sector of the company is cardiology. Medcom Tech SA manufactures defibrillators and implantable devices in this sector. These devices help save lives and provide patients with more security in their daily lives. In particular, implantable devices are an essential part of modern medicine and contribute to allowing patients to lead long and healthy lives. In addition to the mentioned sectors, Medcom Tech also develops and produces devices for the diagnosis and treatment of respiratory diseases, neurology, gynecology, and urology. For example, in urology, a product called ProstateCare has been developed, which is an innovative method for treating benign prostatic hyperplasia (BPH), a benign enlargement of the prostate gland. Medcom Tech SA receives support in these business sectors from a network of international distribution partners who help distribute the products worldwide. In conclusion, Medcom Tech SA has undergone an impressive development and is one of the leading companies in the medical device industry. The company has earned an excellent reputation in the medical industry and is known for its innovative solutions and high-quality products. The continuous collaboration with medical professionals and the consistent development of new technologies and products make Medcom Tech an important partner in the medical care world. Medcom Tech ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding Medcom Tech's P/S Ratio
Medcom Tech's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing Medcom Tech's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating Medcom Tech's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in Medcom Tech’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about Medcom Tech stock
How has the price-earnings ratio of Medcom Tech changed compared to last year?
The price-to-earnings ratio of Medcom Tech has increased by -29.41% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Medcom Tech high compared to other companies?
Yes, the price-to-earnings ratio of Medcom Tech is high compared to other companies.
How does an increase in the price-earnings ratio of Medcom Tech affect the company?
An increase in the price-earnings ratio of Medcom Tech would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Medcom Tech affect the company?
A decrease in the price-earnings ratio of Medcom Tech would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Medcom Tech?
Some factors that influence the price-earnings ratio of Medcom Tech are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Medcom Tech pay?
Over the past 12 months, Medcom Tech paid a dividend of 0.03 EUR . This corresponds to a dividend yield of about 3.4 %. For the coming 12 months, Medcom Tech is expected to pay a dividend of 0 EUR.
What is the dividend yield of Medcom Tech?
The current dividend yield of Medcom Tech is 3.4 %.
When does Medcom Tech pay dividends?
Medcom Tech pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Medcom Tech?
Medcom Tech paid dividends every year for the past 0 years.
What is the dividend of Medcom Tech?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Medcom Tech located?
Medcom Tech is assigned to the 'Health' sector.
Wann musste ich die Aktien von Medcom Tech kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Medcom Tech from 1/5/2016 amounting to 0.03 EUR, you needed to have the stock in your portfolio before the ex-date on 1/5/2016.
When did Medcom Tech pay the last dividend?
The last dividend was paid out on 1/5/2016.
What was the dividend of Medcom Tech in the year 2023?
In the year 2023, Medcom Tech distributed 0 EUR as dividends.
In which currency does Medcom Tech pay out the dividend?
The dividends of Medcom Tech are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Medcom Tech
Our stock analysis for Medcom Tech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medcom Tech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.